ArticleDiabetology & metabolic syndrome2026
Genomic ancestry and diversity in individuals with type 1 diabetes from Brazil and Portugal: a descriptive analysis.
Article in Diabetology & metabolic syndrome, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
introductionType 1 diabetes (T1D) is a chronic autoimmune disease with variable incidence worldwide,. with a higher incidence in countries of European ancestry. The present study aimed primarily to evaluate differences in genomic ancestry (GA) and genetic diversity (GD) between individuals with T1D in Brazil and Portugal compared with healthy control. Secondarily, we aimed to compare the GA and to compare the GA of individuals with T1D from different regions of Brazil with those from Portugal.
methodsThe sample included 1,698 Brazilians and 107 Portuguese individuals with T1D, whose data were analyzed using Ancestry Informative Markers (46-AIMs-Indels) to estimate the proportion of European, African, and Native American (NAM) ancestry. Allele frequencies for short (1) and long (2) alleles were estimated for all individuals. Fragment genotyping was performed by capillary electrophoresis using the ABI 3500 sequencer (Applied Biosystems). The data were analyzed using GeneMapper V.4.1 (Life Technologies, USA). STRUCTURE v2.3.3 software was used to estimate individual ancestry, with K values ranging from 2 to 5 to assess the robustness of the inferred ancestry proportions based on the HGDP-CEPH diversity panel (H952 subset) as a reference for ancestral populations. Genetic parameters were estimated using the software Arlequin v3.5.2.2
resultsThe results revealed a predominance of European GA in both populations, with higher European GA in Portugal and higher African and NAM GA in Brazil. A higher GD was observed in individuals with T1D from Brazil compared with those from Portugal. Non-admixed individuals with T1D from Portugal exhibited high genetic homogeneity and low genetic diversity. Individuals with T1D from the Northern Region of Brazil presented the greatest genetic differentiation compared to regional control groups..
conclusionThis study identifies differences in GA and GD among individuals with T1D from Brazil and Portugal. Considering the dynamics of migrations and admixture in both countries, our data should drive future research areas related to identifying other genetic variants, such as the HLA system alleles (risk or protection) in Brazil and Portugal, which may contribute to a better understanding of the pathogenesis of the disease in both countries.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.